
Sojournix Advances Phase 2 Clinical Trial of SJX‑653 for Menopausal Hot Flashes
WALTHAM, Mass. – December 8, 2020 – Sojournix, a clinical-stage biopharmaceutical company developing transformative medicines
WALTHAM, Mass. – December 8, 2020 – Sojournix, a clinical-stage biopharmaceutical company developing transformative medicines
Violence reduction strategies, which have traditionally focused on pubs and nightclubs, need to be broadened
On a sunny Sunday in April, 20 people were enjoying a barbecue in the city
Researchers from Columbia University have launched CovidWatcher, an app that surveys users about their exposure
It has to be seen to be believed. Feltman’s of Coney Island recently set out
What are the effects of hot beverages on the risk for cancer? Does the temperature